| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
Form 4: Payne Christopher D, Director
Granted 810 Restricted Stock Unit |
| 13 Nov 2026 |
Form 4: Franklin Jonathan M, Chief Accounting Officer
Granted 102,774 Restricted Stock Unit |
| 13 Nov 2026 |
Form 4: Wells David B, Director
Granted 1,051 Restricted Stock Unit |
| 13 Nov 2026 |
Form 4: Huberman Andrew D, Director
Granted 19,301 Restricted Stock Unit |
| 12 Nov 2026 |
Form 3: Huberman Andrew D, Director
No securities owned |
| 09 Nov 2026 | 10-Q |
| 09 Nov 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On November 4, 2026, the board of directors (the “Board”) of Hims & Hers Health, Inc. (the “Company”) increased the size of the Board from nine to ten directors and appointed Dr. Andrew Huberman, 51, to fill the newly created directorshi... |
| 09 Nov 2026 |
8-K: Results of Operations and Financial Condition; Other Events
Revenue of approximately $890 million, up 49% year-over-year in Q3 2026 |
| 30 Oct 2026 | SCHEDULE 13G/A |
| 29 Oct 2026 |
Form 4: Boughton Soleil, Chief Legal Officer
Sold 3,462 shares ($95.6K) |
| 28 Oct 2026 | 144 |
| 15 Oct 2026 |
Form 4: Boughton Soleil, Chief Legal Officer
Sold 3,461 shares ($101K) |
| 15 Oct 2026 |
Form 3: Franklin Jonathan M, Chief Accounting Officer
No securities owned |
| 14 Oct 2026 | 144 |
| 07 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On October 5, 2026, Jonathan M. Franklin commenced employment with Hims & Hers Health, Inc. (the “Company”) as chief accounting officer. On October 7, 2026, the Company's board of directors appointed Mr. Franklin as principal accounting ... |
| 02 Oct 2026 |
Form 4: Okupe Oluyemi, Chief Financial Officer
Sold 2,000 shares ($59.4K) |
| 02 Oct 2026 |
Form 4: Boughton Soleil, Chief Legal Officer
Sold 3,461 shares ($101K) |
| 01 Oct 2026 | 144 |
| 30 Sep 2026 | 144 |
| 23 Sep 2026 |
Form 4: Okupe Oluyemi, Chief Financial Officer
Received 14,000 shares by exercise or conversion ($70.1K) · Sold 29,277 shares ($877K) |
Loading...